# [IKZF3]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |2   |
|DLBCL |2   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|1.62         |
|BL    |Thomas cohort        |0.80         |
|BL    |Panea cohort         |3.00         |
|DLBCL |GAMBL genomes        |4.30         |
|DLBCL |Schmitz cohort       |4.50         |
|DLBCL |Reddy cohort         |3.90         |
|DLBCL |Chapuy cohort        |4.30         |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   | 1.552          |0               |
|DLBCL |Yes |No                   |10.924          |0               |
|FL    |Yes |No                   | 7.180          |0               |

## aSHM regions

|chr_name|hg19_start|hg19_end|region|regulatory_comment|
|--------|----------|--------|------|------------------|
|chr17   |37928959  |37940119|TSS-1 |NA                |
|chr17   |38015776  |38024832|TSS-2 |NA                |

> [!NOTE]
> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468). First described in DLBCL in 2017 by [Mareschal S](https://pubmed.ncbi.nlm.nih.gov/28479318)